This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Innovations of Jose L Lavandera Diaz
Introduction
Jose L Lavandera Diaz is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of chemistry, particularly in the development of antifungal compounds. With a total of 2 patents, his work has implications for medical and pharmaceutical applications.
Latest Patents
His latest patents include innovative compounds that exhibit antifungal activity. One of his notable inventions is a carbocyclic compound characterized by a specific formula, wherein Z is a tetrahydro-pyrano group selected from various structures. This compound demonstrates antifungal activity when combined with other antifungal agents. Another significant patent involves antifungal sordaridin derivatives, which further contribute to the fight against fungal infections.
Career Highlights
Jose L Lavandera Diaz is associated with Glaxo Wellcome Inc., a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on developing effective treatments for various health conditions. His research and innovations have the potential to improve patient outcomes and advance the field of antifungal therapies.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues, including Juan C Cuevas Zurita and Silvestre Garcia-Ochoa Dorado. These collaborations have fostered a productive environment for innovation and research, leading to the development of impactful solutions in the pharmaceutical sector.
Conclusion
Jose L Lavandera Diaz is a distinguished inventor whose work in antifungal compounds has made a significant impact in the field of medicine. His contributions continue to influence the development of effective treatments for fungal infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
